Comparative of Sequential Application of Pulsed Dye Laser and Potassium-titanyl-phosphate Laser Treatment for Capillary Malformations Versus Single Application
Launched by FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL · Jun 3, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different ways to treat port-wine stains, which are birthmarks caused by abnormal blood vessels in the skin. Researchers want to find out how effective and tolerable three types of laser treatments are: the pulsed dye laser (PDL), the potassium-titanyl-phosphate (KTP) laser, and a combination of both applied one after the other. Each participant in the study will receive all three treatments on different parts of their port-wine stain, and the main goal is to see how much the stains improve. They will also check how much pain participants feel during the treatments and how satisfied they are with the results.
To be eligible for this trial, participants must be at least 18 years old and have a port-wine stain. They should have certain skin types (Fitzpatrick skin types I-IV) and must not have any open wounds in the treatment area, be pregnant, have metal implants nearby, or have specific skin conditions that might cause problems with the treatment. The trial is currently recruiting participants of all genders, and those who join can expect to help researchers learn more about effective treatments for these types of skin marks.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18
- • Fitzpatrick skin types I-IV
- • Presence of port-wine stain
- Exclusion Criteria:
- • Open wounds in treatment area
- • Pregnancy
- • Nearby metal implants
- • Photodermatoses
About Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal
The Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal is a leading research organization dedicated to advancing biomedical science and enhancing patient care through innovative clinical trials. Located in Madrid, Spain, the foundation collaborates closely with healthcare professionals and academic institutions to facilitate cutting-edge research initiatives. Its mission is to foster a multidisciplinary approach to medical research, focusing on translating scientific discoveries into effective therapeutic strategies. By prioritizing patient safety and ethical standards, the foundation aims to contribute significantly to the global body of medical knowledge and improve health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported